Fuerstenfeldbruck, Germany

Micha Feld

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rigontec Gmbh. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Micha Feld. Retrieved from https://idiyas.com/inventor/micha-feld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Micha Feld: Innovator in Biotechnology

Introduction

Micha Feld is a notable inventor based in Fuerstenfeldbruck, Germany. He has made significant contributions to the field of biotechnology and pharmaceuticals. His work focuses on the development of methods for designing RIG-I ligands, which are crucial for advancing therapeutic applications.

Latest Patents

Micha Feld holds 1 patent for his invention titled "Method for designing RIG-I ligands." This patent outlines a sequence motif for identifying potent RIG-I agonists. The invention is directed towards producing RIG-I agonists, which have various uses in medical applications, as defined in the claims of the patent.

Career Highlights

Micha Feld is associated with Rigontec GmbH, a company that specializes in innovative biopharmaceutical solutions. His work at Rigontec has positioned him as a key player in the development of novel therapeutic strategies.

Collaborations

Micha collaborates with Christine Schuberth-Wagner, who is also involved in the research and development efforts at Rigontec GmbH. Their partnership enhances the innovative capabilities of the company.

Conclusion

Micha Feld's contributions to biotechnology through his patent on RIG-I ligands exemplify the importance of innovation in pharmaceuticals. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…